Development and validation of the food allergy severity score
Jazyk angličtina Země Dánsko Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
MR/K010468/1
Medical Research Council - United Kingdom
PubMed
34716996
PubMed Central
PMC9298738
DOI
10.1111/all.15165
Knihovny.cz E-zdroje
- Klíčová slova
- allergic reactions, anaphylaxis, food allergy, score, severity,
- MeSH
- alergeny MeSH
- lidé MeSH
- plocha pod křivkou MeSH
- potravinová alergie * diagnóza MeSH
- potraviny MeSH
- ROC křivka MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- alergeny MeSH
BACKGROUND: The heterogeneity and lack of validation of existing severity scores for food allergic reactions limit standardization of case management and research advances. We aimed to develop and validate a severity score for food allergic reactions. METHODS: Following a multidisciplinary experts consensus, it was decided to develop a food allergy severity score (FASS) with ordinal (oFASS) and numerical (nFASS) formats. oFASS with 3 and 5 grades were generated through expert consensus, and nFASS by mathematical modeling. Evaluation was performed in the EuroPrevall outpatient clinic cohort (8232 food reactions) by logistic regression with request of emergency care and medications used as outcomes. Discrimination, classification, and calibration were calculated. Bootstrapping internal validation was followed by external validation (logistic regression) in 5 cohorts (3622 food reactions). Correlation of nFASS with the severity classification done by expert allergy clinicians by Best-Worst Scaling of 32 food reactions was calculated. RESULTS: oFASS and nFASS map consistently, with nFASS having greater granularity. With the outcomes emergency care, adrenaline and critical medical treatment, oFASS and nFASS had a good discrimination (receiver operating characteristic area under the curve [ROC-AUC]>0.80), classification (sensitivity 0.87-0.92, specificity 0.73-0.78), and calibration. Bootstrapping over ROC-AUC showed negligible biases (1.0 × 10-6 -1.23 × 10-3 ). In external validation, nFASS performed best with higher ROC-AUC. nFASS was strongly correlated (R 0.89) to best-worst scoring of 334 expert clinicians. CONCLUSION: FASS is a validated and reliable method to measure severity of food allergic reactions. The ordinal and numerical versions that map onto each other are suitable for use by different stakeholders in different settings.
Allergy Clinic Copenhagen University Hospital at Herlev Gentofte Copenhagen Denmark
Allergy Department 2nd Pediatric Clinic University of Athens Athens Greece
Allergy Department Hospital Clínico San Carlos IdISSC ARADyAL Madrid Spain
Allergy Department Sotiria Chest Diseases Hospital Athens Greece
Allergy Division Chest Disease Department University Hospital of Strasbourg Strasbourg France
Allergy Dpt 2nd Pediatric clinic University of Athens Athens Greece
Ambulatorio di Allergologia Clinica San Carlo Paderno Dugnano Milan Italy
Children's Hospital and Department of Allergy Landspitali University Hospital Reykjavik Iceland
Clinic for Dermatology and Allergology Kantonsspital St Gallen St Gallen Switzerland
Clinic of Allergy and Asthma Medical University in Sofia Sofia Bulgaria
Clinical and Experimental Sciences Faculty of Medicine University of Southampton Southampton UK
Department of Allergy and Immunology Medical University of Lodz Lodz Poland
Department of Dermatology University Hospital Zurich Zurich Switzerland
Department of Dietetics Salford Royal NHS Foundation Trust Salford UK
Department of Pathophysiology and Allergy Research Medical University of Vienna Vienna Austria
Division of Infection Immunity and Respiratory Medicine University of Manchester Manchester UK
Grupo de Investigación en Alergia IdISSC Madrid Spain
Medical Faculty and Faculty Hospital Pilsen Pilsen Czech Republic
Medical Faculty Vilnius University Vilnius Lithuania
National Heart and Lung Institute Imperial College London London UK
Preventive Medicine Department Hospital Clínico San Carlos IdISSC Madrid Spain
Royal College of Surgeons in Ireland Children's Health Ireland at Temple Street Dublin Ireland
The David Hide Asthma and Allergy Research Centre St Mary's Hospital Isle of Wight UK
Zobrazit více v PubMed
Nwaru BI, Hickstein L, Panesar SS, et al. Prevalence of common food allergies in Europe: a systematic review and meta‐analysis. Allergy. 2014;69:992‐1007. 10.1111/all.12423 PubMed DOI
Dunlop JH, Keet CA. Epidemiology of food allergy. Immunol Allergy Clin North Am. 2018;38:13‐25. 10.1016/j.iac.2017.09.002 PubMed DOI
Panesar SS, Javad S, de Silva D, et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy. 2013;68:1353‐1361. 10.1111/all.12272 PubMed DOI
Worm M, Moneret‐Vautrin A, Scherer K, et al. First European data from the network of severe allergic reactions (NORA). Allergy. 2014;69:1397‐1404. 10.1111/all.12475 PubMed DOI
Turner PJ, Gowland MH, Sharma V, et al. Increase in anaphylaxis‐related hospitalizations but no increase in fatalities: an analysis of United Kingdom national anaphylaxis data, 1992–2012. J Allergy Clin Immunol. 2015;135:956‐963. 10.1016/j.jaci.2014.10.021 PubMed DOI PMC
Tejedor‐Alonso MA, Moro‐Moro M, Mosquera González M, et al. Increased incidence of admissions for anaphylaxis in Spain 1998–2011. Allergy. 2015;70:880‐883. 10.1111/all.12613 PubMed DOI
Grabenhenrich LB, Dölle S, Moneret‐Vautrin A, et al. Anaphylaxis in children and adolescents: The European Anaphylaxis Registry. J Allergy Clin Immunol. 2016;137:1128‐1137. 10.1016/j.jaci.2015.11.015 PubMed DOI
Turner PJ, Baumert JL, Beyer K, et al. Can we identify patients at risk of life‐threatening allergic reactions to food? Allergy. 2016;71:1241‐1255. 10.1111/all.12924 PubMed DOI
Muraro A, Werfel T, Hoffmann‐Sommergruber K, et al. Diagnosis and management of food allergy. Allergy. 2014;69:1008‐1025. 10.1111/all.12429 PubMed DOI
DunnGalvin A, Blumchen K, Timmermans F, et al. APPEAL‐1: a multiple‐country European survey assessing the psychosocial impact of peanut allergy. Allergy. 2020;75:2899‐2908. 10.1159/000375106 PubMed DOI PMC
Crevel RWR, Baumert JL, Baka A, et al. Development and evolution of risk assessment for food allergens. Food Chem Toxicol. 2014;67:262‐276. 10.1016/j.fct.2014.01.032 PubMed DOI
Dubois AEJ, Turner PJ, Hourihane J, et al. How does dose impact on the severity of food‐induced allergic reactions, and can this improve risk assessment for allergenic foods?: Report from an ILSI Europe Food Allergy Task Force Expert Group and Workshop. Allergy. 2018;73:1383‐1392. 10.1111/all.13405 PubMed DOI PMC
Pajno GB, Fernandez‐Rivas M, Arasi S, et al. EAACI Guidelines on allergen immunotherapy: IgE‐mediated food allergy. Allergy. 2018;73:799‐815. 10.1111/all.13319 PubMed DOI
PALISADE Group of Clinical Investigators , Vickery BP, Vereda A, et al. AR101 oral immunotherapy for peanut allergy. N Engl J Med. 2018;22(379):1991‐2001. 10.1056/NEJMoa1812856 PubMed DOI
Fleischer DM, Greenhawt M, Sussman G, et al. Effect of epicutaneous immunotherapy vs placebo on reaction to peanut protein ingestion among children with peanut allergy: the PEPITES randomized clinical trial. JAMA. 2019;321:946‐955. 10.1001/jama.2019.1113 PubMed DOI PMC
Nicolaides RE, Parrish CP, Bird JA. Food allergy immunotherapy with adjuvants. Immunol Allergy Clin North Am. 2020;40:149‐173. 10.1016/j.iac.2019.09.004 PubMed DOI
Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol. 2004;114:371‐376. 10.1016/j.jaci.2004.04.029 PubMed DOI
Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977;1:466‐469. 10.1016/s0140-6736(77)91953-5 PubMed DOI
Ring J. Anaphylactoid reactions to intravenous solutions used for volume substitution. Clin Rev Allergy. 1991;9:397‐414. 10.1007/BF02802316 PubMed DOI
Ring J, Behrendt H. Anaphylaxis and anaphylactoid reactions. Classification and pathophysiology. Clin Rev Allergy Immunol. 1999;17:387‐399. 10.1007/BF02737644 PubMed DOI
Mueller HL. Further experiences with severe allergic reactions to insect stings. N Engl J Med. 1959;261:374‐377. 10.1056/NEJM195908202610803 PubMed DOI
Lockey RF, Turkeltaub PC, Baird‐Warren IA, et al. The Hymenoptera venom study I, 1979–1982: demographics and history‐sting data. J Allergy Clin Immunol. 1988;82:370‐381. 10.1016/s0091-6749(05)80182-4 PubMed DOI
Reisman RE. Natural history of insect sting allergy: relationship of severity of symptoms of initial sting anaphylaxis to re‐sting reactions. J Allergy Clin Immunol. 1992;90:335‐339. 10.1016/s0091-6749(05)80012-0 PubMed DOI
Golden DB, Kwiterovich KA, Kagey‐Sobotka A, Lichtenstein LM. Discontinuing venom immunotherapy: extended observations. J Allergy Clin Immunol. 1998;101:298‐305. 10.1016/S0091-6749(98)70239-8 PubMed DOI
Hourihane JO, Kilburn SA, Dean P, Warner JO. Clinical characteristics of peanut allergy. Clin Exp Allergy. 1997;27:634‐639. 10.1111/j.1365-2222.1997.tb01190.x PubMed DOI
Hourihane JO'B, Grimshaw KEC, Lewis SA, et al. Does severity of low‐dose, double‐blind, placebo‐controlled food challenges reflect severity of allergic reactions to peanut in the community? ClinExp Allergy. 2005;35:1227‐1233. 10.1111/j.1365-2222.2005.02312.x PubMed DOI
Ewan PW, Clark AT. Long‐term prospective observational study of patients with peanut and nut allergy after participation in a management plan. Lancet. 2001;357:111‐115. 10.1016/s0140-6736(00)03543-1 PubMed DOI
Sampson HA. Anaphylaxis and emergency treatment. Pediatrics. 2003;111:1601‐1608. PMID: 12777599. PubMed
Astier C, Morisset M, Roitel O, et al. Predictive value of skin prick tests using recombinant allergens for diagnosis of peanut allergy. J Allergy Clin Immunol. 2006;118:250‐256. 10.1016/j.jaci.2006.04.053 PubMed DOI
Cianferoni A, Garrett JP, Naimi DR, Khullar K, Spergel JM. Predictive values for food challenge‐induced severe reactions: development of a simple food challenge score. Isr Med Assoc J. 2012;14:24‐28. PMID: 22624438. PubMed
Hino A, Maeda T, Haneda Y, et al. [Establishment of "Anaphylaxis Scoring Aichi (ASCA)," a new symptom scoring system to be used in an oral food challenge (OFC)]. Arerugi. 2013;62:968‐979. PMID: 24335424 PubMed
Niggemann B, Beyer K. Time for a new grading system for allergic reactions? Allergy. 2016;71:135‐136. 10.1111/all.12765 PubMed DOI
Dribin TE, Schnadower D, Spergel JM, et al. Severity grading system for acute allergic reactions: A multidisciplinary Delphi study. J Allergy Clin Immunol. 2021;148(21):00047‐56. 10.1016/j.jaci.2021.01.003 PubMed DOI PMC
Bernstein DI, Epstein T, Murphy‐Berendts K, Liss GM. Surveillance of systemic reactions to subcutaneous immunotherapy injections: year 1 outcomes of the ACAAI and AAAAI collaborative study. Ann Allergy Asthma Immunol. 2010;104:530‐535. 10.1016/j.anai.2010.04.008 PubMed DOI PMC
Cox L, Larenas‐Linnemann D, Lockey RF, Passalacqua G. Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. J Allergy Clin Immunol. 2010;125(569–74):574.e1‐574.e7. 10.1016/j.jaci.2009.10.060 PubMed DOI
Cox LS, Sanchez‐Borges M, Lockey RF. World allergy organization systemic allergic reaction grading system: is a modification needed? J Allergy Clin Immunol Pract. 2017;5:58‐62.e5. 10.1016/j.jaip.2016.11.009 PubMed DOI
Epstein TG, Liss GM, Murphy‐Berendts K, Bernstein DI. AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008–2012: an update on fatal and nonfatal systemic allergic reactions. J Allergy Clin Immunol Pract. 2014;2:161‐167. 10.1016/j.jaip.2014.01.004 PubMed DOI
Eller E, Muraro A, Dahl R, Mortz CG, Bindslev‐Jensen C. Assessing severity of anaphylaxis: a data‐driven comparison of 23 instruments. Clin Transl Allergy. 2018;8:29. 10.1186/s13601-018-0215-x PubMed DOI PMC
Vidal C, Rodríguez del Río P, Gude F, et al. Comparison of international systemic adverse reactions due to allergen immunotherapy. J Allergy Clin Immunol Pract. 2019;7:1298‐1305.e3. 10.1016/j.jaip.2018.12.006 PubMed DOI
Arasi S, Nurmatov U, Dunn‐Galvin A, et al. Consensus on DEfinition of Food Allergy SEverity (DEFASE) an integrated mixed methods systematic review. World Allergy Organ J. 2021;14(3):100503. 10.1016/j.waojou.2020.100503 PubMed DOI PMC
Muraro A, Fernandez‐Rivas M, Beyer K, et al. The urgent need for a harmonized severity scoring system for acute allergic reactions. Allergy. 2018;73:1792‐1800. 10.1111/all.13408. PubMed DOI
Moons KGM, Altman DG, Reitsma JB, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162(1):W1‐73. 10.7326/M14-0698 PubMed DOI
Sampson HA, Gerth van Wijk R, Bindslev‐Jensen C, et al. Standardizing double‐blind, placebo‐controlled oral food challenges: American Academy of Allergy, Asthma & Immunology‐European Academy of Allergy and Clinical Immunology PRACTALL consensus report. J Allergy Clin Immunol. 2012;130:1260‐1274. 10.1016/j.jaci.2012.10.017 PubMed DOI
Fernández‐Rivas M, Barreales L, Mackie AR, et al. The EuroPrevall outpatient clinic study on food allergy: background and methodology. Allergy. 2015;70:576‐584. 10.1111/all.12585 PubMed DOI
Kummeling I, Mills ENC, Clausen M, et al. The EuroPrevall surveys on the prevalence of food allergies in children and adults: background and study methodology. Allergy. 2009;64:1493‐1497. 10.1111/j.1398-9995.2009.02046.x PubMed DOI
Roberts G, Allen K, Ballmer‐Weber B, et al. Identifying and managing patients at risk of severe allergic reactions to food: report from two iFAAM workshops. Clin Exp Allergy. 2019;49:1558‐1566. 10.1111/cea.13516 PubMed DOI
Grabenhenrich LB, Reich A, Bellach J, et al. A new framework for the documentation and interpretation of oral food challenges in population‐based and clinical research. Allergy. 2017;72:453‐461. 10.1111/all.13049 PubMed DOI PMC
Fernández‐Rivas M, Bolhaar S, González‐Mancebo E, et al. Apple allergy across Europe: how allergen sensitization profiles determine the clinical expression of allergies to plant foods. J Allergy Clin Immunol. 2006;118:481‐488. 10.1016/j.jaci.2006.05.012 PubMed DOI
Flynn TN, Marley AAJ. Best‐worst scaling: stheory and methods. In: Hess S, Daly A, eds. Handbook of Choice Modelling. Edward Elgar Publishing; 2014:178‐201.
Stafford A, Bartra J, Aston A, et al. Improving severity scoring of food‐induced allergic reactions: a global “Best‐Worst Scaling” exercise. J Allergy Clin Immunol Pract, 2021. (in press). 10.1016/j.jaip.2021.06.056 PubMed DOI PMC
Lemeshow S, Le Gall JR. Modelling the severity of illness of ICU patients. A systems update. JAMA. 1994;272:1049‐1055. PMID: 8089888. PubMed
Grabenhenrich LB, Dölle S, Ruëff F, et al. Epinephrine in severe allergic reactions: The European Anaphylaxis Register. J Allergy Clin Immunol Pract. 2018;6:1898‐1906. 10.1016/j.jaip.2018.02.026 PubMed DOI
Capps JA, Sharma V, Arkwright PD. Prevalence, outcome and pre‐hospital management of anaphylaxis by first aiders and paramedical ambulance staff in Manchester, UK. Resuscitation. 2010;81:653‐657. 10.1016/j.resuscitation.2010.01.021 PubMed DOI
Dubus J‐C, Lê M‐S, Vitte J, et al. Use of epinephrine in emergency department depends on anaphylaxis severity in children. Eur J Pediatr. 2019;178:69‐75. 10.1007/s00431-018-3246-3 PubMed DOI
Sampson HA, Muñoz‐Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report – Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol. 2006;117:391‐397. 10.1016/j.jaci.2005.12.1303 PubMed DOI
Turner PJ, Worm M, Ansotegui IJ, et al. Time to revisit the definition and clinical criteria for anaphylaxis? World Allergy Organ J. 2019;12(10):100066. 10.1016/j.waojou.2019.100066 PubMed DOI PMC